ArticleThe Journal of clinical investigation2007

B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.

Diana Cozma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.